Skip to main content
Literatur
1.
Zurück zum Zitat Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146–60.CrossRefPubMedPubMedCentral Jolles S, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015;179:146–60.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Datta R, Kuruvilla M, Gill M, de la Morena MT. Association of skin necrosis with subcutaneous immunoglobulin therapy. Ann Allergy Asthma Immunol. 2014;113:232–3.CrossRefPubMed Datta R, Kuruvilla M, Gill M, de la Morena MT. Association of skin necrosis with subcutaneous immunoglobulin therapy. Ann Allergy Asthma Immunol. 2014;113:232–3.CrossRefPubMed
3.
Zurück zum Zitat Ponsford M, Carne E, Kingdon C, Joyce C, Price C, Williams C, et al. Facilitated subcutaneous immunoglobulin (fSCIg) therapy—practical considerations. Clin Exp Immunol. 2015;182:302–13.CrossRefPubMedPubMedCentral Ponsford M, Carne E, Kingdon C, Joyce C, Price C, Williams C, et al. Facilitated subcutaneous immunoglobulin (fSCIg) therapy—practical considerations. Clin Exp Immunol. 2015;182:302–13.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Jain S, Pandey K, Lahoti A, Rao P. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naive, type-2 diabetic adult population. Indian J Endocrinol Metab. 2013;17:864–70.CrossRefPubMedPubMedCentral Jain S, Pandey K, Lahoti A, Rao P. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin naive, type-2 diabetic adult population. Indian J Endocrinol Metab. 2013;17:864–70.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kang DW, Jadin L, Nekoroski T, Drake FH, Zepeda ML. Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model. Drug Deliv Transl Res. 2012;2:254–64.CrossRefPubMed Kang DW, Jadin L, Nekoroski T, Drake FH, Zepeda ML. Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model. Drug Deliv Transl Res. 2012;2:254–64.CrossRefPubMed
Metadaten
Titel
Skin Necrosis Following Subcutaneous Immunoglobulin (SCIg)
verfasst von
Emily Carne
Mark Ponsford
Tariq El-Shanawany
Stephen Jolles
Publikationsdatum
28.10.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2017
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0346-6

Weitere Artikel der Ausgabe 1/2017

Journal of Clinical Immunology 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.